Evidence map›Paper›PMID 40685364›Full record

ArticleParasites & vectors2025

High prevalence of vector-borne pathogens in the blood of clinically healthy dogs in Hong Kong.

Thamali Manathunga, Mariaelisa Carbonara, Omid Nekouei, Jairo Alfonso Mendoza-Roldan, Wing Yan Jacqueline Tam, Frederic Beugnet, Domenico Otranto, Vanessa R Barrs

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Geographical Distribution and Molecular Characterization ofAnimals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thamali ManathungaDepartment of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong.
Mariaelisa CarbonaraDepartment of Veterinary Medicine, University of Bari, Bari, Italy.
Omid NekoueiDepartment of Infectious Diseases and Public Health, City University of Hong Kong, Kowloon Tong, Hong Kong.
Jairo Alfonso Mendoza-RoldanDepartment of Veterinary Medicine, University of Bari, Bari, Italy.
Wing Yan Jacqueline TamDepartment of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong.
Frederic BeugnetBoehringer-Ingelheim Animal Health, Lyon, France.
Domenico OtrantoDepartment of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong. domenico.otranto@uniba.it.
Vanessa R BarrsDepartment of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong. vanessa.barrs@cityu.edu.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeishmaniosis and other canine vector-borne diseases (CVBDs) pose a major risk for veterinary and public health globally, especially where humans and dogs live in close proximity. Although mosquito and tick vectors are abundant in Hong Kong, surveillance for CVBDs has been limited.

methodsA serological and molecular survey of 158 healthy owned (n = 64) and free-roaming unowned (n = 94) dogs with outdoor access in Hong Kong was performed to determine CVBD prevalence. Point-of-care (POC) immunoassays were used to detect (i) antibodies to Leishmania spp., Ehrlichia spp., and Anaplasma spp., and (ii) Dirofilaria immitis and Angiostrongylus vasorum antigens, in canine sera. Conventional polymerase chain reaction (PCR) was also carried out to detect the molecular prevalence of all five pathogens as well as Hepatazoon canis, Babesia gibsoni, and Trypanosoma evansi. In addition, for Leishmania spp. detection, an immunofluorescence antibody test (IFAT) was performed on all serum samples, followed by real-time PCR of seropositive samples to detect Leishmania spp. DNA. The agreement between tests was assessed by Cohen's kappa statistic, and logistic regression analysis was applied to identify potential risk factors.

resultsOverall, 45.6% of dogs tested positive on molecular and/or serological tests for at least one pathogen, with the highest prevalence recorded for Dirofilaria spp. (20.9%), followed by B. gibsoni (15.2%), Leishmania spp. (11.4%), Anaplasma spp. (7.6%), H. canis (4.4%), Ehrlichia spp. (3.8%), and A. vasorum (0.6%). No T. evansi DNA was detected. Co-infections or co-pathogen exposure occurred in 16.5% of samples. Of the 33 Dirofilaria spp.-positive dogs, two were identified by sequencing as Dirofilaria asiatica, and the remaining 31 were D. immitis. No significant risk factors for infection or exposure were identified.

conclusionsThis is the first epidemiological survey of Leishmania spp. infection in dogs from Hong Kong, highlighting the need for surveillance of competent vectors and further investigation of disease status in dog populations to confirm whether this pathogen is endemic. Given the high prevalence of CVBD, especially of D. immitis, preventive and control measures are advocated in order to mitigate risks to canine health and zoonotic infection.

Indexed as

Blood-Borne PathogensDog DiseasesVector Borne DiseasesAnaplasmaAnimalsAntibodies, BacterialAntibodies, ProtozoanDirofilaria immitisDirofilariasisDogsFemaleHong KongLeishmaniaLeishmaniasisMalePrevalenceAntibodies, BacterialAntibodies, ProtozoanAnaplasma spp.Babesia gibsoniCanine vector-borne diseasesDirofilaria asiaticaDirofilaria spp.Ehrlichia canisHepatozoon canisHong KongLeishmania spp.Trypanosoma evansi

Identifiers

PMID40685364
PMCPMC12278506

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.